Dimed Sa (ex Panvel Sa Drogarias Farmacias) (PNVL3R) Quote

All I can say is be careful what you wish for. AI is very dangerous. You see the comments from MAGA.

https://www.youtube.com/watch?v=7wkotY0SsO4

GGB,

I've asked this question before, even if Keytruda is very effective when used with DCVax-L and it's proven in trials, how does that protect Keytruda if generic forms of it are available.

How does a trial with Keytruda that's successful prevent someone from using D

shyster /shi'st?r/
noun

An unethical, unscrupulous practitioner, especially of law. A trickish knave; one who carries on any business, especially legal business, in a mean and dishonest way. Someone who acts in a disreputable, unethical, or unscrupulous way, especially in the p

BIEL VA HUGE!
https://veteranrecovery.org/

Huh? Freak.

Regulators require clinical evidence and other than GBM, NWBO has no other evidence.

After the full MONI audit report...

https://i.imgflip.com/9oec3j.gif

Yeah flights were way different then. I can remember flying Paris to Vancouver BC and the captain apologized that the coffee and tea service had to be stopped until the flight cleared some turbulence!

Bill and Hillary speaches in Berlin at the World Forum 2025 on the Future of Democracy

https://youtu.be/23la2NKdBHo?si=0ej7fJuzdpjRM97t

https://youtu.be/_DZ4TdjCmQc?si=5q7V7EjQuEMxICx2

Much ado about nothing....

This is what I said (as you quoted): "DCVax works, targeting all tumor-based cancers, is highly scalable, and is extensively protected by patents." Is this not true, please explain?!

DCVax has demonstrated promising results in glioblastoma (n

If the contract comes from the USA through lqmt we are outsourcing to Eontec/yihao same as Evie ring.

Eontec cannot cancel, modify or ignore. They are being outsourced for the job.

“Eon (via Yihao) will produce the part under the cost plus contract”

Get i

Tell me about it marie....No wonder dems are at 29 and 21%........No wonder they lost, No wonder they are lost in the woods now.........

Thanks

Looks like you will be able to get that 7.50 target. Congrats.

I wonder why CEO’s don’t do back to back smaller reverse splits, so as to not shock the markets, if they really feel the need to have a better share structure or price?

Given the situation here, with rising share accumulation the past 7 weeks, it wouldn’t bother me if I saw something

Agree 100%. It shouldn’t come as a surprise to anyone if it happens. They said so themselves in a 2023 release. There is also the possibility of delisting from otc and going ipo route. Anything is possible.

Yep but they are not willing to lend them 50M under non toxic terms , to keep the lights on . Try harder

IMO..Park's latest PR is designed to blunt the reaction when his 2024 annual report drops. It's due on Saturday (90 days after end of fiscal year)..possibly the next business day (Monday the 31st).

As I read the following PR, Datang is the latest in his list of partners whom he clai

The only review I'm interested in is the margin review.

Jon Ossoff in Atlanta.
https://youtu.be/sEFzw21cx7Q?si=KIMr-y38BopATH1E

I mostly agree with that, But they will be advised to do what is needed to uplist and either they do or don't...Getting the sp to what they need is a lot easier with a 5 million float  and much more inviting to Institutional investors vs the current structure. Either way, it is what is.

Tesla readings
https://x.com/robinivski/status/1903829152395923708?s=46

Also fits like a glove with couple posters here, lol.....No congrats , thanks anyway. Fallacies are about the only language spoken here.....Not many honest brokers ;)

It’s no-wonder TPT joined SAMENA Council for international leverage.

Medesol Coronacide scam repeats itself at $MGON. Beware!!!!
https://i.giphy.com/5QMOICVmXremPSa0k7.webp

Gary don't sell the company short. Merck gets $25 billion per year revenue from Keytruda. I think they'd be happy to pay $25B for Nwbo to extend their patent out another 10 years and prevent anyone else from having this treatment. Not to mention all the patents and Flaskworks. And that would probab